HUP9900251A3 - Pharmaceutical compositions containing hedgehog proteins and use of former compositions - Google Patents

Pharmaceutical compositions containing hedgehog proteins and use of former compositions

Info

Publication number
HUP9900251A3
HUP9900251A3 HU9900251A HUP9900251A HUP9900251A3 HU P9900251 A3 HUP9900251 A3 HU P9900251A3 HU 9900251 A HU9900251 A HU 9900251A HU P9900251 A HUP9900251 A HU P9900251A HU P9900251 A3 HUP9900251 A3 HU P9900251A3
Authority
HU
Hungary
Prior art keywords
former
hedgehog proteins
pharmaceutical compositions
compositions
compositions containing
Prior art date
Application number
HU9900251A
Other languages
Hungarian (hu)
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of HU9900251D0 publication Critical patent/HU9900251D0/en
Publication of HUP9900251A2 publication Critical patent/HUP9900251A2/en
Publication of HUP9900251A3 publication Critical patent/HUP9900251A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
HU9900251A 1998-02-04 1999-02-03 Pharmaceutical compositions containing hedgehog proteins and use of former compositions HUP9900251A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98101893 1998-02-04
EP98104416 1998-03-12

Publications (3)

Publication Number Publication Date
HU9900251D0 HU9900251D0 (en) 1999-03-29
HUP9900251A2 HUP9900251A2 (en) 1999-09-28
HUP9900251A3 true HUP9900251A3 (en) 2001-01-29

Family

ID=26149005

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900251A HUP9900251A3 (en) 1998-02-04 1999-02-03 Pharmaceutical compositions containing hedgehog proteins and use of former compositions

Country Status (14)

Country Link
JP (1) JP3092706B2 (en)
KR (2) KR100311565B1 (en)
CN (1) CN1228994A (en)
AT (1) ATE331533T1 (en)
AU (1) AU713568B2 (en)
CA (1) CA2260423C (en)
CZ (1) CZ33799A3 (en)
DE (1) DE69932113T2 (en)
HU (1) HUP9900251A3 (en)
IL (1) IL128329A (en)
MA (1) MA26602A1 (en)
NO (1) NO990471L (en)
NZ (1) NZ334065A (en)
SG (1) SG66504A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
KR100452752B1 (en) * 2000-04-18 2004-10-12 주식회사 펩트론 Preparation Method of sustained release dosage forms of protein drugs and the drugs prepared by that method
KR101705323B1 (en) * 2010-03-23 2017-02-13 코웨이 주식회사 Water purifier of reverse osmosis type
CN102174794B (en) * 2011-03-07 2012-08-15 江苏科技大学 Automatic leveling system and method for six-point support bridging platform
KR102176832B1 (en) * 2017-11-29 2020-11-10 주식회사 파이안바이오테크놀로지 A microparticle comprising hedgehog protein and biocompatible material and a composition for preventing or treating hair loss comprising the same

Also Published As

Publication number Publication date
JP2000119193A (en) 2000-04-25
DE69932113D1 (en) 2006-08-10
NO990471D0 (en) 1999-02-01
KR100311565B1 (en) 2001-11-02
NO990471L (en) 1999-08-05
NZ334065A (en) 2000-06-23
HUP9900251A2 (en) 1999-09-28
SG66504A1 (en) 2000-07-18
AU713568B2 (en) 1999-12-02
ATE331533T1 (en) 2006-07-15
JP3092706B2 (en) 2000-09-25
HU9900251D0 (en) 1999-03-29
DE69932113T2 (en) 2007-01-25
MA26602A1 (en) 2004-12-20
CZ33799A3 (en) 1999-08-11
IL128329A (en) 2005-08-31
IL128329A0 (en) 2000-01-31
CA2260423C (en) 2006-06-20
CN1228994A (en) 1999-09-22
CA2260423A1 (en) 1999-08-04
KR19990072406A (en) 1999-09-27
KR19990072423A (en) 1999-09-27
AU1542699A (en) 1999-08-26

Similar Documents

Publication Publication Date Title
HUP9902655A3 (en) Pharmaceutical composition of hedgehog proteins and use thereof
HUP0101999A3 (en) 4-hydroxyquinoline-3-carboxamides and hydrazides use of them and pharmaceutical compositions containing them
HUP0103874A3 (en) Use of antibiotics and pharmaceutical compositions comprising thereof
EG24044A (en) pharmaceutical formulation of omeprazole
PL354168A1 (en) Pharmaceutical composition of nateglinide and another antidiabetcagent
HUP9702035A3 (en) Inhibitors of leukocita-adhesion- and vla-4-antagonists and pharmaceutical compositions containing them
HUP9702036A3 (en) Inhibitors of leucocita-adhesion and wla-4-antagonists and pharmaceutical compositions containing them
HUP9702034A3 (en) Inhibitors of leukocita-adhesion and vla-4-antagonists and pharmaceutical compositions containing them
HUP0001309A3 (en) 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
HUP0100149A3 (en) Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
HUP0202862A3 (en) Pharmaceutical composition containing novel combination of loteprednol and antihistamines
ZA984266B (en) Pharmaceutical composition and process of preparation
HU9800147D0 (en) Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
LT99141A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
IL123927A (en) Propanolamine derivatives processes for their preparation and pharmaceutical composition comprising them
GB9808840D0 (en) Treatment of depression and pharmaceutical preparations therefor
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
HUP0001858A3 (en) Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
HUP0102025A3 (en) Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use
HUP0101733A3 (en) Pharmaceutical compositions containing sulfonyl-dipeptides and their use
IL132516A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
HUP9900251A3 (en) Pharmaceutical compositions containing hedgehog proteins and use of former compositions